Agenus Inc. (AGEN)

Business: Agenus Inc., a clinical-stage immuno-oncology company, discovers and develops immuno-oncology products in the United States and internationally.

IPO Date: 04-Feb-2000

Founder, Exec. Chairman & CEO: Dr. Garo H. Armen Ph.D.

VP of Fin., Principal Financial Officer & Principal Accounting Officer: Ms. Christine M. Klaskin

Listing: NASDAQ: AGEN

Country: United States

Headquarters: Lexington, MA

Website: https://www.agenusbio.com

Market cap: $509.46 Mln

Revenue (TTM): $309.89 Mln

Earnings (TTM): $-19.43 Mln

Cash: $262.69 Mln

Total Debt: $64.31 Mln

Insider's Holding: 10.10%

Liquidity: Low

52 Week range: $1.25 - 6.79

Shares outstanding: 270,991,008

10 Years Aggregate:

• CFO: $-556.84 Mln
• EBITDA: $-589.96 Mln
• Net Profit: $-896.44 Mln